Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Iguratimod

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,928Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Jiangsu Chiatai Qingjiang Pharmaceutical
    China
    		 Jiangsu Chiatai Qingjiang Pharmaceutical Co. , Ltd. 305MF10057 Iguratimod 2023-05-10 2024-07-24 No. 9 Hantai North Road, Qinghe District, Huai'an City, Jiangsu Province, P. R. China
    26/09/2024 Jiangsu Chiatai Qingjiang Pharmaceutical
    China
    		 Jiangsu Chiatai Qingjiang Pharmaceutical Co. , Ltd. 302MF10085 Igurachimod 2020-07-22 2023-08-02 No. 9 Hantai North Road, Qinghe District, Huai'an City, Jiangsu Province, P. R. China